Guidelines
by
The College of Physicians and Surgeons of Newfoundland and Labrador
Release Date
2020
Geography
Canada
Language of Resource
English
Full Text Available
Yes
Open Access / OK to Reproduce
No
Peer Reviewed
No
Objective
Provide clinical guidance to ensure the uninterrupted access to OAT medications for patients during the COVID-19 pandemic.
Findings/Key points
This document provides an interim guideline for the management of OAT. It addresses office visits, remote visits, carry doses and the frequency of urine drug testing during the COVID-19 pandemic in the light of the need for social distancing, self-isolation and quarantining.
Keywords
Clinical guidance
Harm reduction
About pharmacists
About prescribers
